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Adoptive T cell therapy (ACT) is growing rapidly, representing the revolution in cancer treatment. However, the 
current manufacturing platforms are largely based on magnetic microbeads surface coated with agonist 
antibodies to T-cell receptors CD3 and CD28. These manufacturing platforms use expensive reagents including 
the viral transduction vectors, and also require multiple discrete stages and open processes with significant 
human interaction, contributing to the high-cost for cGMP manufacturing of these therapies.  
We developed a single-
use, beads-free 
bioreactor system (Figure 
1a), which provides a 
closed-loop T-cell 
activation and expansion. 
The perfusion-based 
platform also facilitates 
the development of the 
bioreactor system into a 
fully automated, turn-key 




settings. The bioreactor has a unique internal structure (Figure 1b), formed by a large number of interconnected 
hollow spheres tightly packed in a 3D space, which yields large surface areas to increase the reactivity between 
the bioreactor and the T cells flowing through the bioreactor. The 
surfaces of the bioreactor are coated with anti-CD3 and CD28 
antibodies to mimic the antigens for T activation and expansion.   
The feasibility of using the perfusion-based bioreactor for T-cell 
activation and expansion is demonstrated in Figure 2. Briefly, 
20x106 PBMCs were seeded into the bioreactor system and 
perfused for two days during the T-cell activation phase, with the 
medium containing no cytokine IL2. After two-day of activation, 
human IL-2 was added to the system so that the total IL-2 
concentration was 20 IU/mL. Then the T-cell expansion phase was 
carried out for three-days. On Day 5, T cells were achieved a 
three-time expansion after activation, which is similar to the 
magnetic beads-based system. However, the perfusion based 
bioreactor has the potential to offer multiple advantages over the 
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Figure 2: T-cell expansion in the 
perfusion bioreactor. 
 
